Clinical trial
A Randomized Controlled Study to Explore the Effect of Stellate Ganglion Block in Dysphagic Patients With Bulbar Palsy After Ischemic Stroke
NCT06225076 is registered in ClinicalTrials.gov with Zeng Changhao as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Study to Explore the Effect of Stellate Ganglion Block in Dysphagic Patients With Bulbar Palsy After Ischemic Stroke
- Lead sponsor
- Zeng Changhao
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- January 30, 2024
- Completion date
- May 30, 2024
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bulbar palsy